The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Clinical · Comorbidities

Chronic kidney disease and the FLOW result — a second dataset

CT
c.tullochTL28 Oct 2024#1

Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did.

Posting a small dataset on Chronic kidney disease. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately.

What I would like is not agreement but a second dataset collected by someone with no stake in mine. If one exists I would rather read it than argue for this one.

11 likes 22mo
MM
m.marchettiTL231 Oct 2024#2

The opening post is the version of this I will quote in future. One addition.

Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that person requires reasoning from the individual component trials and mechanisms.

One of those cases where knowing the mechanism does not help the decision.

1 like 21mo
HH
h.hutchingsTL1Member16 Nov 2024#3
m.marchetti, post #2: The opening post is the version of this I will quote in future. One addition. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that person requires reasoning from the individual component trials and mechanisms. One of those… Go to post

Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.

30 likes in reply to #2 20mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Hepatic steatosis: what the MASH trial evidence supports
Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on hepatic steatosis, before…
CMPCNLSMA+77 83 950 13mo
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about osteoarthritis and mechanical versus metabolic…
NANRFKLWDP+2 6 30k 12h
[2026 update] Gastro-oesophageal reflux: improving or worsening?
Asking directly, because I could not find a straight answer: Gastro-oesophageal reflux: improving or worsening? Gastro-oesophageal reflux — I have the observation and I do not trust my interpretation of it,…
EFFIMDN 3 782 13mo
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
OBFATWAKMS+120 129 1.8k 13mo
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
SOAWKRLDNL+99 103 32k 11mo

Related topics — sharing the tags MASH / hepatic steatosis, blood pressure, type 2 diabetes

TopicParticipantsRepliesViewsActivity
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Good consultation: what I expected, what I found, and the…
GIJSATYAS+32 36 13k 1mo
What to bring: records that a clinician can actually use
Asking directly, because I could not find a straight answer: What to bring: records that a clinician can actually use A question about how to describe something to a clinician rather than about the thing…
ATAPCLAIPM+15 19 6.4k 1d
Coming back to: What the published dose-response for semaglutide actually looks like above 2.4 mg
The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody repeats it. I would like to know what…
SCHJSATKO+23 27 9.9k 1mo
The headache that turns out to be dehydration
The headache that turns out to be dehydration Writing it up because I had to work it out twice and would rather nobody else did. Reporting what I changed and what happened, with the caveat that I changed two…
MBKTBIMN+143 158 7.8k 6mo
When your prescriber and the evidence disagree
When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked. What changes if the standard account of prescriber is wrong? I ask…
YERDKFKVKP+14 18 273 2d